AGEN logo

Agenus Inc. (AGEN)

Profile

Full Name

Agenus Inc.

Ticker

NASDAQ: AGEN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 8, 2000

Indexes

Not included

Website

https://www.agenusbio.com

Employees

316

Key Details

Price

$4.63(+1.76%)

Market cap

$147.53M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$103.46M(-33.81% YoY)

Annual EPS

-$10.59(+23.26% YoY)

PE ratio

-

Next earnings date

Nov 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.63
    AGEN price is $4.63

    30-Day Relative Volume

    0.42
    AGEN 30-day relative volume is 0.42

    Price Performance

    Price Most recent change

    +1.76%
    AGEN price was up +1.76% on Aug 15, 2025

    Price YTD change

    +68.98%
    AGEN price is up +68.98% since January 1st

    Price 1-year change

    -10.44%
    AGEN price is down -10.44% year-on-year

    Price 3-year change

    -92.49%
    AGEN price is down -92.49% over the past 3 years

    Price Range

    Price All-time high

    $7065.75
    AGEN price is currently -99.93% below its historical high of $7065.75

    Price 3-year low

    $1.38
    AGEN price is currently +235.51% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $147.53M
    AGEN market capitalization is $147.53 million

    Market cap 3-year change

    -83.09%
    AGEN market capitalization is down -83.09% over the past 3 years

    Market cap All-time high

    $4.59B
    AGEN market capitalization is currently -96.78% below its historical high of $4.59 billion

    Market cap sector rank

    47.43%
    AGEN market capitalization is higher than 47.43% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +47.71%
    AGEN shares outstanding is up +47.71% year-on-year

    Shares Outstanding 3-Year Change

    +125.06%
    AGEN shares outstanding is up +125.06% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.51
    AGEN beta is 1.51

    200-day SMA

    $3.60
    AGEN price is currently +28.45% above its 200-day simple moving average

    50-day SMA

    $5.38
    AGEN price is currently -13.89% below its 50-day simple moving average

    RSI

    41.50
    AGEN 14-day relative strength index is 41.50

    Volume

    0.42
    AGEN 30-day relative volume is 0.42

    ATR

    $0.41
    AGEN average true range is $0.41

    10-day Historical Volatility

    106.72%
    AGEN 10-day historical volatility is 106.72%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $103.46M
    AGEN annual revenue is $103.46 million

    Revenue Analysts estimate

    $165.97M
    AGEN annual revenue is currently -37.66% lower than the consensus analysts' forecast

    Revenue 1-year change

    -33.81%
    AGEN annual revenue is down -33.81% year-on-year

    Revenue Sector rank

    68.78%
    AGEN annual revenue is higher than 68.78% of companies in Healthcare sector

    EPS

    EPS

    -$10.59
    AGEN annual earnings per share is -$10.59

    EPS Analysts estimate

    -$0.95
    AGEN annual earnings per share is currently +1014.74% higher than the consensus analysts' forecast

    EPS 1-year change

    +23.26%
    AGEN annual earnings per share is up +23.26% year-on-year

    EPS Sector rank

    12.37%
    AGEN annual earnings per share is higher than 12.37% of companies in Healthcare sector

    Profit

    Gross profit

    $89.63M
    AGEN annual gross profit is $89.63 million

    Gross margin

    86.63%
    AGEN annual gross profit margin is 86.63%

    Operating profit

    -$124.43M
    AGEN annual operating income is -$124.43 million

    Operating margin

    -120.26%
    AGEN annual operating profit margin is -120.26%

    Net income

    -$232.27M
    AGEN annual net profit is -$232.27 million

    Net margin

    -224.50%
    AGEN annual net profit margin is -224.50%

    Expenses

    Total expenses

    $330.68M
    AGEN annual total expenses is $330.68 million

    Operating expenses

    $214.06M
    AGEN annual total operating expenses is $214.06 million

    Cost of goods sold

    $13.83M
    AGEN annual cost of goods sold is $13.83 million

    Selling, general & administrative expenses

    $0.00
    AGEN annual SGA is $0.00

    Depreciation and amortization

    $13.34M
    AGEN annual depreciation & amortization is $13.34 million

    Interest expense

    $0.00
    AGEN annual interest expense is $0.00

    Income tax

    $0.00
    AGEN annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$124.43M
    AGEN annual earnings before interest & taxes is -$124.43 million

    EBITDA

    -$111.09M
    AGEN annual EBITDA is -$111.09 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $226.27M
    AGEN annual total assets is $226.27 million

    Non current assets

    $180.70M
    AGEN annual long term assets is $180.70 million

    Current assets

    $45.57M
    AGEN annual total current assets is $45.57 million

    Cash and cash equivalents

    $40.44M
    AGEN annual cash & cash equivalents is $40.44 million

    Accounts receivable

    $407.00K
    AGEN annual accounts receivable is $407.00 thousand

    Inventory

    $0.00
    AGEN annual inventory is $0.00

    Liabilities

    Total liabilities

    $532.70M
    AGEN annual total liabilities is $532.70 million

    Long term liabilities

    $311.29M
    AGEN annual total long term liabilities is $311.29 million

    Current liabilities

    $221.40M
    AGEN annual total current liabilities is $221.40 million

    Accounts payable

    $61.47M
    AGEN annual accounts payable is $61.47 million

    Debt

    Total debt

    $94.87M
    AGEN annual total debt is $94.87 million

    Total debt 1-year change

    +7.24%
    AGEN annual total debt is up +7.24% year-on-year

    Long term debt

    $85.02M
    AGEN annual long term debt is $85.02 million

    Short term debt

    $9.85M
    AGEN annual short term debt is $9.85 million

    Equity & Capital

    Shareholders equity

    -$326.38M
    AGEN annual stockholders equity is -$326.38 million

    Book value

    -$326.38M
    AGEN annual book value is -$326.38 million

    Retained earnings

    -$2.18B
    AGEN annual retained earnings is -$2.18 billion

    Working capital

    -$175.83M
    AGEN annual working capital is -$175.83 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$158.31M
    AGEN annual cash flow from operations is -$158.31 million

    Cash from operations 1-year change

    +29.39%
    AGEN annual cash flow from operations is up +29.39% year-on-year

    Cash from investing

    $27.00K
    AGEN annual cash flow from investing activities is $27.00 thousand

    Cash from investing 1-year change

    -99.21%
    AGEN annual cash flow from investing activities is down -99.21% year-on-year

    Cash from financing

    $122.84M
    AGEN annual cash flow from financing activities is $122.84 million

    Cash from financing 1-year change

    +2.48%
    AGEN annual cash flow from financing activities is up +2.48% year-on-year

    CAPEX

    CAPEX

    $576.00K
    AGEN annual capital expenditures is $576.00 thousand

    CAPEX 1-year change

    -94.21%
    AGEN annual capital expenditures is down -94.21% year-on-year

    Free Cash Flow

    Free cash flow

    -$158.89M
    AGEN annual free cash flow is -$158.89 million

    Free cash flow 1-year change

    +32.14%
    AGEN annual free cash flow is up +32.14% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    86.63%
    AGEN annual gross profit margin is 86.63%

    Operating margin

    -120.26%
    AGEN annual operating profit margin is -120.26%

    Net margin

    -224.50%
    AGEN annual net profit margin is -224.50%

    ROA & ROE

    ROA

    -86.00%
    AGEN annual return on assets is -86.00%

    ROE

    71.17%
    AGEN annual return on equity is 71.17%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AGEN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AGEN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.42
    AGEN price to book ratio is -0.42

    PB ratio Sector rank

    12.19%
    AGEN price to book ratio is higher than 12.19% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.45
    AGEN price to sales ratio is 1.45

    PS ratio Sector rank

    29.95%
    AGEN price to sales ratio is higher than 29.95% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $228.52M
    AGEN enterprise value is $228.52 million

    Enterprise value Sector rank

    53.87%
    AGEN enterprise value is higher than 53.87% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.05
    AGEN EV/EBITDA is -3.05

    EV/EBITDA Sector rank

    32.69%
    AGEN EV/EBITDA is higher than 32.69% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.21
    AGEN annual current ratio is 0.21

    Quick ratio

    0.21
    AGEN annual quick ratio is 0.21

    Leverage

    Debt to equity

    -1.32
    AGEN annual debt to equity ratio is -1.32

    Interest coverage ratio

    -
    AGEN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    2
    AGEN piotroski f-score is 2

    Altman Z-Score

    -15.63
    AGEN altman z-score is -15.63

    Analyst ratings

    Recent major analysts updates

    Jun 4, 25 HC Wainwright & Co.
    Buy
    Jun 4, 25 Baird
    Neutral
    May 13, 25 HC Wainwright & Co.
    Neutral
    May 13, 25 Baird
    Neutral
    Apr 30, 25 HC Wainwright & Co.
    Neutral
    Mar 18, 25 HC Wainwright & Co.
    Neutral
    Mar 12, 25 HC Wainwright & Co.
    Neutral
    Mar 12, 25 Baird
    Neutral
    Jan 22, 25 HC Wainwright & Co.
    Neutral
    Dec 5, 24 HC Wainwright & Co.
    Neutral

    Institutional Ownership

    Screeners with AGEN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Agenus Inc.?
    • Does Agenus Inc. pay dividends?
    • What sector is Agenus Inc. in?
    • What industry is Agenus Inc. in?
    • What country is Agenus Inc. based in?
    • When did Agenus Inc. go public?
    • Is Agenus Inc. in the S&P 500?
    • Is Agenus Inc. in the NASDAQ 100?
    • Is Agenus Inc. in the Dow Jones?
    • When was Agenus Inc.'s last earnings report?
    • When does Agenus Inc. report earnings?

    What is the ticker symbol for Agenus Inc.?

    The ticker symbol for Agenus Inc. is NASDAQ:AGEN

    Does Agenus Inc. pay dividends?

    No, Agenus Inc. does not pay dividends

    What sector is Agenus Inc. in?

    Agenus Inc. is in the Healthcare sector

    What industry is Agenus Inc. in?

    Agenus Inc. is in the Biotechnology industry

    What country is Agenus Inc. based in?

    Agenus Inc. is headquartered in United States

    When did Agenus Inc. go public?

    Agenus Inc.'s initial public offering (IPO) was on February 8, 2000

    Is Agenus Inc. in the S&P 500?

    No, Agenus Inc. is not included in the S&P 500 index

    Is Agenus Inc. in the NASDAQ 100?

    No, Agenus Inc. is not included in the NASDAQ 100 index

    Is Agenus Inc. in the Dow Jones?

    No, Agenus Inc. is not included in the Dow Jones index

    When was Agenus Inc.'s last earnings report?

    Agenus Inc.'s most recent earnings report was on August 11, 2025

    When does Agenus Inc. report earnings?

    The next expected earnings date for Agenus Inc. is November 10, 2025
    On this page